MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$61,236K
Restricted cash
$42K
Short-term investments
$149,540K
Total cash, cash
equivalents and restricted...
$61,278K
Prepaid expenses and
other current assets
$4,405K
Accounts and other
receivables
$845K
Income tax and r&d
incentive receivables
$547K
Total current assets
$216,615K
Other assets
$1,495K
Property and equipment,
net
$337K
Total assets
$218,447K
Total liabilities and
stockholders' equity
$218,447K
Total stockholders'
equity
$185,601K
Total liabilities
$32,846K
Accumulated deficit
-$622,125K
Accumulated other
comprehensive loss, net
-$5,016K
Additional paid-in capital
$812,732K
Term loan,
noncurrent
$14,445K
Total current
liabilities
$12,606K
Other noncurrent
liabilities
$5,795K
Common stock, 0.0001
par value...
$10K
Accrued expenses and
other current...
$7,802K
Accounts payable
$4,804K
Back
Back
Balance Sheet
source: myfinsight.com
Altimmune, Inc. (ALT)
Altimmune, Inc. (ALT)